jamunjar-logo
whatsapp
cartmembermenu

GAD 65 Antibody by IFA (for Paraneoplastic syndrome)

Unit Test
image

Report in 24Hrs

image

At Home

Details

It helps identify autoimmune neurologic disorders, type 1 diabetes, and certain paraneoplastic syndromes

81908990

9% OFF

customers1000+ Booked this Test

🧪 What is GAD65 Antibody by IFA?

GAD65 (Glutamic Acid Decarboxylase 65) is an autoantibody targeting the enzyme responsible for synthesizing GABA, the main inhibitory neurotransmitter in the CNS.

  • The test detects GAD65 autoantibodies in blood or CSF using IFA (Indirect Immunofluorescence Assay).
  • It helps identify autoimmune neurologic disorders, type 1 diabetes, and certain paraneoplastic syndromes.

❓ Why is the Test Done?

To detect GAD65 autoimmunity in:

  1. Neurological Autoimmune Disorders:
    • Stiff-person syndrome (SPS)
    • Autoimmune cerebellar ataxia
    • Limbic encephalitis
    • Epilepsy (autoimmune origin)
    • Paraneoplastic neurologic syndromes
  2. Endocrine Autoimmunity:
    • Type 1 Diabetes Mellitus (T1DM)
    • Latent Autoimmune Diabetes in Adults (LADA)
  3. Paraneoplastic Syndromes:
    • Rare neurological syndromes associated with cancer (often breast, lung, or thymoma)

🔬 Method: Indirect Immunofluorescence Assay (IFA)

  • Patient serum is incubated on slides coated with tissue expressing GAD.
  • Fluorescent antibodies are added to detect bound autoantibodies.
  • Positive result shows fluorescence patterns indicating GAD65 autoantibodies.

📊 Normal Range

Test

Reference

GAD65 Antibody (IFA)

Negative (no specific fluorescence detected)

Some labs may report semi-quantitative values or titres (e.g., low, moderate, high positive).

📈 Interpretation of Results

Result

Possible Interpretation

Negative

No GAD65 autoimmunity detected

Low Positive

Early or mild autoimmune process (e.g., LADA, mild neurologic symptoms)

High Positive

Strong association with autoimmune neurologic disorders or paraneoplastic syndromes

🧠 Associated Organs and Conditions

System

Condition

Nervous System

- Stiff-person syndrome (SPS)
- Cerebellar ataxia
- Limbic encephalitis
- Myoclonus, epilepsy

Pancreas (Islets of Langerhans)

Type 1 Diabetes, LADA

Paraneoplastic Sites

Breast, lung (small cell), thymoma, other tumors with ectopic GAD expression

🔄 Related / Follow-Up Tests

  1. Other Paraneoplastic Antibodies:
    • Anti-Hu, Anti-Yo, Anti-Ri, Anti-Ma2, CRMP-5
  2. CSF Analysis: In neurologic disease
  3. MRI Brain: For limbic encephalitis or cerebellitis
  4. Electromyography (EMG): In stiff-person syndrome
  5. Cancer screening: Mammogram, CT thorax/abdomen, PET-CT
  6. C-peptide, HbA1c: In suspected LADA or diabetes

✅ Fasting Required?

Parameter

Fasting Required

GAD65 Antibody (IFA)

❌ No fasting required

📝 Summary Table

Parameter

Details

What

Detects autoantibodies against GAD65 enzyme using IFA

Why

Diagnose autoimmune neurologic disorders, T1DM, paraneoplastic syndromes

Normal Range

Negative (no autoantibodies)

Positive Result

Indicates GAD65 autoimmunity (e.g., SPS, ataxia, limbic encephalitis, LADA)

Associated Conditions

Stiff-person syndrome, paraneoplastic neurological syndromes, T1DM

Follow-up Tests

Paraneoplastic panel, CSF, MRI, cancer screen

Fasting Required

❌ No

How our test process works!

customers
customers